Supporting decision-making in the clinical management of dengue using predictive and prescriptive modeling
DOI:
https://doi.org/10.19153/cleiej.28.6.5Abstract
Dengue is a vector-borne tropical disease that is widely distributed throughout the world. The clinical management of dengue consists of diagnosis and treatment of the disease. The development of approaches to aid decision-making in this disease is necessary to reduce morbidity and mortality rates. Despite the existence of guidelines for clinical management, the diagnosis and treatment of dengue remain a challenge. To address this problem, we aimed to develop methodologies, models, and approaches to support decision-making regarding the clinical management of this infection. We developed several works to meet the proposed objectives. First, we reviewed the latest trends in dengue modeling using machine learning (ML) techniques. Then, we proposed a decision support system for dengue diagnosis using fuzzy cognitive maps (FCM). Subsequently, we developed an autonomous cycle of data analysis tasks (ACODAT) to support both diagnosis and treatment of the disease. Also, we presented a methodology based on FCM and optimization algorithms to generate prescriptive models in various science domains. Finally, we proposed three federated learning approaches to ensure the security and privacy of data related to the clinical management of dengue. These strategies were evaluated using diverse datasets with signs, symptoms, laboratory tests, and information related to disease treatment. The results showed the ability of the developed methodologies and models to predict the disease, classify patients according to severity, evaluate the behavior of severity-related variables, and recommend treatments based on World Health Organization (WHO) guidelines.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 William Hoyos, Jose Aguilar, Mauricio Toro

This work is licensed under a Creative Commons Attribution 4.0 International License.
CLEIej is supported by its home institution, CLEI, and by the contribution of the Latin American and international researchers community, and it does not apply any author charges whatsoever for submitting and publishing. Since its creation in 1998, all contents are made publicly accesibly. The current license being applied is a (CC)-BY license (effective October 2015; between 2011 and 2015 a (CC)-BY-NC license was used).